Trial Profile
A Single-Center, Three-Part, Open Label Study to Evaluate the Relative Bioavailability of Two Formulations, Food Effect, and Interaction With Itraconazole Following Single Dose of GSK2140944 in Healthy Subjects and Effect of Food on Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of GSK2140944 in Healthy Elderly Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2023
Price :
$35
*
At a glance
- Drugs Gepotidacin (Primary) ; Itraconazole
- Indications Respiratory tract infections; Skin and soft tissue infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
- 02 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.